This section provides various financial ratios derived from the company's financial statements to help assess its performance and financial health. Below are Current Ratio, Quick Ratio, Cash Ratio for APRE as of 2026-03-31.
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash Ratio | 877.276 | 528.128 | 511.656 | 521.904 |
| Quick Ratio | 891.988 | 562.924 | 520.083 | 534.374 |
| Current Ratio | 891.988 | 562.924 | 520.083 | 534.374 |
Aprea Therapeutics, Inc. (APRE)
Aprea Therapeutics, Inc. (APRE)